Affiliation:
1. Division of Toxicology, Institute for Medical Research and Occupational Health, 10000 Zagreb, Croatia
2. Department of Medical Biochemistry, Faculty of Medicine, University of Latvia, 1004 Riga, Latvia
3. Genetics and Bioinformatics, Institute of Biology, University of Latvia, 1004 Riga, Latvia
Abstract
Among the various natural compounds used in alternative and Oriental medicine, toxins isolated from different organisms have had their application for many years, and Apis mellifera venom has been studied the most extensively. Numerous studies dealing with the positive assets of bee venom (BV) indicated its beneficial properties. The usage of bee products to prevent the occurrence of diseases and for their treatment is often referred to as apitherapy and is based mainly on the experience of the traditional system of medical practice in diverse ethnic communities. Today, a large number of studies are focused on the antitumor effects of BV, which are mainly attributed to its basic polypeptide melittin (MEL). Previous studies have indicated that BV and its major constituent MEL cause a strong toxic effect on different cancer cells, such as liver, lung, bladder, kidney, prostate, breast, and leukemia cells, while a less pronounced effect was observed in normal non-target cells. Their proposed mechanisms of action, such as the effect on proliferation and growth inhibition, cell cycle alterations, and induction of cell death through several cancer cell death mechanisms, are associated with the activation of phospholipase A2 (PLA2), caspases, and matrix metalloproteinases that destroy cancer cells. Numerous cellular effects of BV and MEL need to be elucidated on the molecular level, while the key issue has to do with the trigger of the apoptotic cascade. Apoptosis could be either a consequence of the plasmatic membrane fenestration or the result of the direct interaction of the BV components with pro-apoptotic and anti-apoptotic factors. The interaction of BV peptides and enzymes with the plasma membrane is a crucial step in the whole process. However, before its possible application as a remedy, it is crucial to identify the correct route of exposure and dosage of BV and MEL for potential therapeutic use as well as potential side effects on normal cells and tissues to avoid any possible adverse event.
Funder
European Regional Development Fund
European Union—Next Generation EU
Reference200 articles.
1. From Demons to Darlings: Drugs from Venoms;Harvey;Drug Discov. Today,1998
2. Modern Venomics-Current Insights, Novel Methods, and Future Perspectives in Biological and Applied Animal Venom Research;Anderluh;Gigascience,2022
3. Sjakste, N., and Gajski, G. (2023). A Review on Genotoxic and Genoprotective Effects of Biologically Active Compounds of Animal Origin. Toxins, 15.
4. Strategies for Discovering Drugs from Previously Unexplored Natural Products;Harvey;Drug Discov. Today,2000
5. Current Strategies for Drug Discovery through Natural Products;Harvey;Expert Opin. Drug Discov.,2010
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献